Multiple insiders report open-market share purchases
TradeXchange flagged open-market insider purchases across several companies, including CRBG, GME, PAM, ACOG, FGBI and VCIG.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
TradeXchange flagged open-market insider purchases across several companies, including CRBG, GME, PAM, ACOG, FGBI and VCIG.
The article says insiders are buying shares at Boston Scientific, Cardinal Infrastructure Group, GBank Financial Holdings and Amrize after sharp stock declines. It highlights large open-market purchases by Boston Scientific CEO Michael Mahoney and Cardinal CEO Jeremy Spivey, along with buying by other executives and di
MIND Technology said second-quarter fiscal 2027 revenue was $5.6 million, with gross profit of $2.1 million, operating loss of $1.8 million and net loss of $1.7 million.
Multiple insider purchases reported on the open market: ATRA director buys 104,166 shares for $9.60 (total $999,994); ENOV CAO buys 7,598 shares for $19.738 (total $149,971) and CEO buys 13,035 for $19.15 (total $249,620).
Multiple insiders reported $100K+ purchases on the open market: BAER Director bought 200,000 shares at $1.096; JUSH CEO bought 319,686 at $0.517; ADC Director bought 10,000 at $72.42; RCT owner bought 2,500,000 at $0.25.
Insiders reported $100K+ open-market purchases in JUSH (CEO) and AMRC (Director and CEO), with other transactions listed across multiple officers and owners. Total amounts and per-share prices were provided for each buy.